X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aurobindo Pharma with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ORCHID PHARMA LTD - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ORCHID PHARMA LTD AUROBINDO PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 13.8 -0.2 - View Chart
P/BV x 3.0 0.1 2,544.8% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 AUROBINDO PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-18
ORCHID PHARMA LTD
Sep-13
AUROBINDO PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs809194 417.0%   
Low Rs50435 1,440.0%   
Sales per share (Unadj.) Rs281.1276.5 101.7%  
Earnings per share (Unadj.) Rs41.4-79.2 -52.2%  
Cash flow per share (Unadj.) Rs50.9-43.5 -117.1%  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs199.453.9 369.6%  
Shares outstanding (eoy) m585.8870.45 831.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.30.4 564.0%   
Avg P/E ratio x15.9-1.4 -1,098.2%  
P/CF ratio (eoy) x12.9-2.6 -489.7%  
Price / Book Value ratio x3.32.1 155.1%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m384,6308,067 4,768.2%   
No. of employees `00017.32.8 619.0%   
Total wages/salary Rs m21,3082,527 843.2%   
Avg. sales/employee Rs Th9,500.76,956.1 136.6%   
Avg. wages/employee Rs Th1,229.4902.5 136.2%   
Avg. net profit/employee Rs Th1,397.9-1,993.0 -70.1%   
INCOME DATA
Net Sales Rs m164,66619,477 845.4%  
Other income Rs m1,020407 250.4%   
Total revenues Rs m165,68619,884 833.3%   
Gross profit Rs m37,7181,103 3,420.8%  
Depreciation Rs m5,5802,519 221.5%   
Interest Rs m7775,227 14.9%   
Profit before tax Rs m32,380-6,236 -519.2%   
Minority Interest Rs m3120 159.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m8,183-125 -6,535.7%   
Profit after tax Rs m24,229-5,580 -434.2%  
Gross profit margin %22.95.7 404.6%  
Effective tax rate %25.32.0 1,258.7%   
Net profit margin %14.7-28.7 -51.4%  
BALANCE SHEET DATA
Current assets Rs m121,87811,014 1,106.6%   
Current liabilities Rs m86,80632,060 270.8%   
Net working cap to sales %21.3-108.1 -19.7%  
Current ratio x1.40.3 408.7%  
Inventory Days Days13095 136.9%  
Debtors Days Days6834 203.7%  
Net fixed assets Rs m81,03729,440 275.3%   
Share capital Rs m586705 83.2%   
"Free" reserves Rs m116,2182,043 5,689.7%   
Net worth Rs m116,8043,800 3,073.9%   
Long term debt Rs m4,5129,018 50.0%   
Total assets Rs m211,05246,510 453.8%  
Interest coverage x42.7-0.2 -22,091.4%   
Debt to equity ratio x02.4 1.6%  
Sales to assets ratio x0.80.4 186.3%   
Return on assets %11.8-0.8 -1,558.9%  
Return on equity %20.7-146.9 -14.1%  
Return on capital %27.4-3.7 -732.5%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m80,7277,513 1,074.5%   
Fx outflow Rs m34,7005,649 614.3%   
Net fx Rs m46,0271,865 2,468.6%   
CASH FLOW
From Operations Rs m19,5481,682 1,162.4%  
From Investments Rs m-19,570-9,860 198.5%  
From Financial Activity Rs m8,6426,644 130.1%  
Net Cashflow Rs m8,922-1,535 -581.2%  

Share Holding

Indian Promoters % 54.1 32.3 167.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.0 4.6 172.8%  
FIIs % 27.7 3.3 839.4%  
ADR/GDR % 0.0 4.6 -  
Free float % 10.2 55.3 18.4%  
Shareholders   69,601 84,811 82.1%  
Pledged promoter(s) holding % 8.6 54.9 15.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   GLENMARK PHARMA  FULFORD INDIA  WYETH LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare AUROBINDO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (up 19.3% YoY). Sales on the other hand came in at Rs 53 bn (up 21.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now(Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks(The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Aug 23, 2019 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS